Rexulti was approved in 2018 for the treatment of schizophrenia in adults.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/lundbeck-drug-receives-eu-approval-for-treatment-of-schizophrenia-in-adolescents/
Rexulti was approved in 2018 for the treatment of schizophrenia in adults.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/lundbeck-drug-receives-eu-approval-for-treatment-of-schizophrenia-in-adolescents/